VOCIMAGENE AMIRETROREPVEC
UNII DC4WO3WA4Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Vocimagene Amiretrorepvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DC4WO3WA4Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1300724-82-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DC4WO3WA4Q

CAS Registry Number

1300724-82-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VOCIMAGENE AMIRETROREPVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C91734

National Cancer Institute reference terminology for clinical and research data.

INN ID

9603

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

YY-147

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vocimagene Amiretrorepvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VOCIMAGENE AMIRETROREPVEC

Common Names & Synonyms

RECOMBINANT REPLICATION-COMPETENT RETROVIRUS VECTOR ENCODING A HUMAN CODON OPTIMIZED YEAST CYTOSINE DEAMINASE GENE, CARRYING THREE STABILIZING POINT MUTATIONS (A23L/ V108T/I140L) AND TRANSLATED VIA AN EMCV IRES (ENCEPHALOMYOCARDITIS VIRUS INTERNAL RIBOSOMAL ENTRY SITE)

VOCIMAGENE AMIRETROREPVEC [INN]

VOCIMAGENE AMIRETROREPVEC [USAN]

VOCIMAGENE AMIRETROREPVEC [WHO-DD]